Kamada KMDA
NASDAQ KMDA
$8.46 -0.23 (-2.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

Kamada (KMDA) Net Income (2012 - 2026)

Updated

Kamada (KMDA) recorded Net Income of $9.26 million in the quarter ended Jun 30, 2026, up 25.6% from $7.38 million a year earlier and up 124.2% from the prior quarter.

Analysis

Kamada (KMDA) Net Income (2012 - 2026) Analysis & Trends

On a TTM basis, Kamada's Net Income came in at $22.25 million as of Jun 30, 2026, up 17.0% year-over-year; for the year ended Dec 31, 2025, it was $20.2 million, up 39.7% from the prior year.

  • Annual Net Income has a five-year compound annual growth rate of 3.3% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Net Income came in at $14.46 million in the year ended Dec 31, 2024 (+74.6%), $8.28 million in the year ended Dec 31, 2023, -$2.32 million in the year ended Dec 31, 2022 and -$2.23 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Net Income since the quarter ended Dec 31, 2018.
  • On a year-over-year basis, Net Income rose in six of the last eight quarters, with growth averaging 23.7%.
  • Peak year-over-year performance for Net Income in the last five years was growth of 565.9% in the quarter ended Sep 30, 2023, against a decline of 24.7% in the quarter ended Dec 31, 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $4.13 million (quarter ended Mar 31, 2026), $3.56 million (quarter ended Dec 31, 2025) and $5.3 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.51 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -237.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 Kamada 488.02 Mn 197.08 Mn 22.47 Mn 9.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.26 Mn
Mar 31, 2026 4.13 Mn
Dec 31, 2025 3.56 Mn
Sep 30, 2025 5.30 Mn
Jun 30, 2025 7.38 Mn
Mar 31, 2025 3.96 Mn
Dec 31, 2024 3.81 Mn
Sep 30, 2024 3.86 Mn
Jun 30, 2024 4.43 Mn
Mar 31, 2024 2.37 Mn
Dec 31, 2023 5.06 Mn
Sep 30, 2023 3.22 Mn
Jun 30, 2023 1.81 Mn
Mar 31, 2023 -1.81 Mn
Dec 31, 2022 2.94 Mn
Sep 30, 2022 484,000.00
Jun 30, 2022 -3.92 Mn
Mar 31, 2022 -1.83 Mn
Dec 31, 2021 -5.01 Mn
Sep 30, 2021 -845,000.00
API Access

Kamada Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=KMDA&period=max&api_key=YOUR_API_KEY